Objective neurovascular monitoring in feet of Type 2 diabetes patients

• Research type

  Research Study

• Full title

  Comparison of transcutaneous oxygen and nerve conduction devices against existing methods to determine neurovascular status in the feet of adult participants with Type 2 Diabetes in the community

• IRAS ID

  170265

• Contact name

  Simbarashe Richard Tanyanyiwa

• Contact email

  srt1e14@soton.ac.uk

• Sponsor organisation

  University of Southampton

• Duration of Study in the UK

  1 years, 1 months, 27 days

• Research summary

  This research will test 2 machines, the Precise Medicap 8001, and the NCstat-DPN-Check; that use the skin to test the blood supply and nerve function respectively, to see if these machines are better at finding changes that occur in the feet of adults with Type 2 diabetes, when compared to current methods. This will help to better identify people at risk of developing diabetes foot complications.
  Later complications with diabetes happen because it is difficult for current methods to see the changes in the nerves and blood supply early enough. As a result, by the time changes are seen, it is often too late to make improvements, and the patient is then more likely to have ulcers and amputations. This affects the patient's well-being and health, as well as putting more pressure on health services. It is known that these changes are often first seen in the feet. Therefore, being able to find these changes sooner and follow them as they change, would give more information to patients and other people involved in their care. The information from these tools will allow for earlier treatment, and see if it is effective, and can lead to better control of the diabetes, therefore preventing the problems that can happen later. The machines are non-invasive and easily portable, and use the skin to see these early changes in the nerves and blood supply in the feet of people with type 2 diabetes. This research will see if they give more useful information and see at what stage patients are on their diabetes journey, when compared to the other common methods used today.

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  17/LO/2033

• Date of REC Opinion

  1 Dec 2017

• REC opinion

  Favourable Opinion